BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9499119)

  • 1. Suppression of v-src transformation by the drs gene.
    Inoue H; Pan J; Hakura A
    J Virol; 1998 Mar; 72(3):2532-7. PubMed ID: 9499119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene.
    Yamashita A; Hakura A; Inoue H
    Oncogene; 1999 Aug; 18(34):4777-87. PubMed ID: 10490811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
    Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
    Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.
    Yoshioka N; Inoue H; Nakanishi K; Oka K; Yutsudo M; Yamashita A; Hakura A; Nojima H
    J Virol; 2000 Jan; 74(2):1008-13. PubMed ID: 10623765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epiderstatin induces the flat reversion of NRK cells transformed by temperature-sensitive Rous sarcoma virus.
    Osada H; Sasaki M; Sonoda T; Isono K
    Biosci Biotechnol Biochem; 1992 Nov; 56(11):1801-6. PubMed ID: 1369411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of fibronectin gene expression in v-src transformation.
    Gu H; Oliver N
    Exp Cell Res; 1995 Apr; 217(2):428-39. PubMed ID: 7698243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
    Verderame MF; Kaplan JM; Varmus HE
    J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
    Durkin JP; Whitfield JF
    J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the pRb-binding regions of E1A enables efficient transformation of primary epithelial cells by v-src.
    Fischer RS; Quinlan MP
    J Virol; 1998 Apr; 72(4):2815-24. PubMed ID: 9525601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia.
    Stoker AW; Hatier C; Bissell MJ
    J Cell Biol; 1990 Jul; 111(1):217-28. PubMed ID: 2164029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.
    Pierani A; Pouponnot C; Calothy G
    Mol Cell Biol; 1993 Jun; 13(6):3401-14. PubMed ID: 8388536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the catalytic domain of pp60v-src is responsible for the host- and temperature-dependent phenotype of the Rous sarcoma virus mutant tsLA33-1.
    Foster R; Martin GS
    Virology; 1992 Mar; 187(1):145-55. PubMed ID: 1310553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum independence of transcription from the promoter of an avian retrovirus in v-src-transformed cells is a primary, intracellular effect of increased tyrosine phosphorylation.
    Dutta A; Hamaguchi M; Hanafusa H
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):608-12. PubMed ID: 1689046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of c-Src and Csk in fibroblasts transformed by v-src oncogene.
    Tuhácková Z; Vojtechová M; Hlavácek J; Ruzzene M; Sovová V; Pinna LA
    Biochem Biophys Res Commun; 2002 Jan; 290(2):790-5. PubMed ID: 11785970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of drs mRNA in human colon adenocarcinomas.
    Shimakage M; Kawahara K; Kikkawa N; Sasagawa T; Yutsudo M; Inoue H
    Int J Cancer; 2000 Jul; 87(1):5-11. PubMed ID: 10861446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A host-dependent temperature-sensitive mutant of Rous sarcoma virus: evidence for host factors affecting transformation.
    Young JC; Liebl E; Martin GS
    Virology; 1988 Oct; 166(2):561-72. PubMed ID: 2845662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.
    Florio M; Wilson LK; Trager JB; Thorner J; Martin GS
    Mol Biol Cell; 1994 Mar; 5(3):283-96. PubMed ID: 8049521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.
    Catling AD; Fincham VJ; Frame MC; Haefner B; Wyke JA
    J Virol; 1994 Jul; 68(7):4392-9. PubMed ID: 8207813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.